142 related articles for article (PubMed ID: 27139139)
21. Synthesis and in vitro evaluation of a PDT active BODIPY-NLS conjugate.
Verwilst P; David CC; Leen V; Hofkens J; de Witte PA; De Borggraeve WM
Bioorg Med Chem Lett; 2013 Jun; 23(11):3204-7. PubMed ID: 23639541
[TBL] [Abstract][Full Text] [Related]
22. Pyrrolopyrrole aza-BODIPY near-infrared photosensitizer for dual-mode imaging-guided photothermal cancer therapy.
Wu C; Huang X; Tang Y; Xiao W; Sun L; Shao J; Dong X
Chem Commun (Camb); 2019 Jan; 55(6):790-793. PubMed ID: 30569923
[TBL] [Abstract][Full Text] [Related]
23. Insights into the binding mechanism of BODIPY-based photosensitizers to human serum albumin: A combined experimental and computational study.
Chen Y; Liu J; Song M; Jiang L; Liu L; Liu Y; Fu G; Xue J; Liu JY; Huang M; Li J
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Oct; 203():158-165. PubMed ID: 29864639
[TBL] [Abstract][Full Text] [Related]
24. Thienopyrrole-expanded BODIPY as a potential NIR photosensitizer for photodynamic therapy.
Yang Y; Guo Q; Chen H; Zhou Z; Guo Z; Shen Z
Chem Commun (Camb); 2013 May; 49(38):3940-2. PubMed ID: 23536148
[TBL] [Abstract][Full Text] [Related]
25. A disulfide-linked conjugate of ferrocenyl chalcone and silicon(IV) phthalocyanine as an activatable photosensitiser.
Lau JT; Jiang XJ; Ng DK; Lo PC
Chem Commun (Camb); 2013 May; 49(39):4274-6. PubMed ID: 23135340
[TBL] [Abstract][Full Text] [Related]
26. pH-Responsive supramolecular vesicles assembled by water-soluble pillar[5]arene and a BODIPY photosensitizer for chemo-photodynamic dual therapy.
Meng LB; Zhang W; Li D; Li Y; Hu XY; Wang L; Li G
Chem Commun (Camb); 2015 Oct; 51(76):14381-4. PubMed ID: 26270623
[TBL] [Abstract][Full Text] [Related]
27. In vivo targeted magnetic resonance imaging and visualized photodynamic therapy in deep-tissue cancers using folic acid-functionalized superparamagnetic-upconversion nanocomposites.
Zeng L; Luo L; Pan Y; Luo S; Lu G; Wu A
Nanoscale; 2015 May; 7(19):8946-54. PubMed ID: 25920333
[TBL] [Abstract][Full Text] [Related]
28. A biotin-conjugated glutathione-responsive FRET-based fluorescent probe with a ferrocenyl BODIPY as the dark quencher.
Shi WJ; Lo PC; Zhao S; Wong RC; Wang Q; Fong WP; Ng DK
Dalton Trans; 2016 Nov; 45(44):17798-17806. PubMed ID: 27774548
[TBL] [Abstract][Full Text] [Related]
29. An integrin-targeting glutathione-activated zinc(II) phthalocyanine for dual targeted photodynamic therapy.
Ha SYY; Wong RCH; Wong CTT; Ng DKP
Eur J Med Chem; 2019 Jul; 174():56-65. PubMed ID: 31029944
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
J Photochem Photobiol B; 2014 Nov; 140():140-9. PubMed ID: 25123528
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and In Vitro Evaluation of a Photosensitizer-BODIPY Derivative for Potential Photodynamic Therapy Applications.
Gorbe M; Barba-Bon A; de la Torre C; Gil S; Costero AM; Sancenón F; Murguía JR; Martínez-Máñez R
Chem Asian J; 2015 Oct; 10(10):2121-5. PubMed ID: 26282179
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy.
Lim SH; Thivierge C; Nowak-Sliwinska P; Han J; van den Bergh H; Wagnières G; Burgess K; Lee HB
J Med Chem; 2010 Apr; 53(7):2865-74. PubMed ID: 20199028
[TBL] [Abstract][Full Text] [Related]
33. meso-Methylhydroxy BODIPY: a scaffold for photo-labile protecting groups.
Rubinstein N; Liu P; Miller EW; Weinstain R
Chem Commun (Camb); 2015 Apr; 51(29):6369-72. PubMed ID: 25761909
[TBL] [Abstract][Full Text] [Related]
34. A Local CC2 and TDA-DFT Double Hybrid Study on BODIPY/aza-BODIPY Dimers as Heavy Atom Free Triplet Photosensitizers for Photodynamic Therapy Applications.
Momeni MR; Brown A
J Phys Chem A; 2016 Apr; 120(16):2550-60. PubMed ID: 27035753
[TBL] [Abstract][Full Text] [Related]
35. Two novel BODIPY-Ru(ii) arene dyads enabling effective photo-inactivation against cancer cells.
Wang T; Hou Y; Chen Y; Li K; Cheng X; Zhou Q; Wang X
Dalton Trans; 2015 Jul; 44(28):12726-34. PubMed ID: 26087131
[TBL] [Abstract][Full Text] [Related]
36. Red fluorescent BODIPY-based nanoparticles for targeted cancer imaging-guided photodynamic therapy.
Kim C; Mai DK; Kim WJ; Badon IW; Jo J; Kang D; Kim SJ; Kim HJ; Yang J
Biomater Sci; 2024 Mar; 12(6):1536-1548. PubMed ID: 38299265
[TBL] [Abstract][Full Text] [Related]
37. Photosensitizer that selectively generates singlet oxygen in nonpolar environments: photophysical mechanism and efficiency for a covalent BODIPY dimer.
Zhang XF; Yang X
J Phys Chem B; 2013 Aug; 117(30):9050-5. PubMed ID: 23837434
[TBL] [Abstract][Full Text] [Related]
38. Boron dipyrromethene (BODIPY) functionalized carbon nano-onions for high resolution cellular imaging.
Bartelmess J; De Luca E; Signorelli A; Baldrighi M; Becce M; Brescia R; Nardone V; Parisini E; Echegoyen L; Pompa PP; Giordani S
Nanoscale; 2014 Nov; 6(22):13761-9. PubMed ID: 25286147
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of peptide-conjugated phthalocyanine photosensitizers with highly hydrophilic modifications.
Li F; Liu Q; Liang Z; Wang J; Pang M; Huang W; Wu W; Hong Z
Org Biomol Chem; 2016 Apr; 14(13):3409-22. PubMed ID: 26956169
[TBL] [Abstract][Full Text] [Related]
40. Phthalocyanine-polyamine conjugates as highly efficient photosensitizers for photodynamic therapy.
Jiang XJ; Yeung SL; Lo PC; Fong WP; Ng DK
J Med Chem; 2011 Jan; 54(1):320-30. PubMed ID: 21138268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
